Breast tumor imaging with ultra low field MRI

Area of Science:

• Medical Imaging
• Oncology
• Biophysics

Background:

• Breast cancer diagnosis relies on accurate imaging techniques.
• Ultra low field MRI offers a potentially lower-cost, more accessible alternative to conventional MRI.
• Understanding tissue relaxation times (T1 and T2) is crucial for MRI-based tissue characterization.

Purpose of the Study:

• To evaluate the efficacy of ultra low field MRI for preoperative breast tumor imaging.
• To assess the diagnostic performance and reliability of T1 and T2 relaxation time measurements in breast tumors.

Main Methods:

• Preoperative ultra low field MRI using T2-weighted gradient-echo sequences in 27 patients with suspected breast malignancy.
• In vivo and in vitro measurements of T1 and T2 relaxation times using additional IR- and gradient-echo sequences.
• Comparison of MRI findings with mammography and histopathology.

Main Results:

• MRI detected 19 out of 23 mammographically detected carcinomas (83% sensitivity).
• Specificity was 75% with one benign case misclassified.
• Tumor T1 and T2 relaxation times were generally longer than normal breast parenchyma, with significant differences noted for T1 and T2 versus parenchyma, and T1 versus fat.

Conclusions:

• Ultra low field MRI demonstrates potential for detecting breast tumors, correlating with mammography findings.
• While statistically significant differences in relaxation times were observed, they were not sufficiently reliable for clinical diagnosis.
• Further research is needed to improve the reliability of ultra low field MRI parameters for breast cancer assessment.